Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank80
3Y CAGR-19.5%
5Y CAGR-10.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-19.5%/yr
vs +107.4%/yr prior
5Y CAGR
-10.2%/yr
Recent deceleration
Acceleration
-126.9pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.30M | +3.6% |
| 2025 | $20.55M | +27.4% |
| 2024 | $16.13M | -60.4% |
| 2023 | $40.77M | -12.1% |
| 2022 | $46.39M | +27.3% |
| 2021 | $36.43M | +339.9% |
| 2020 | $8.28M | +276.1% |
| 2019 | $2.20M | +7.4% |
| 2018 | $2.05M | +44.7% |
| 2017 | $1.42M | - |